EPO published patent EP4514276A1 for bone implant systems and methods filed by Catalyst OrthoScience Inc. on March 25, 2026. The patent application covers A61F 2/40 (shoulder implants) and A61F 2/30 (joint implants) classifications and designates all EU member states, Switzerland, Norway, and other European jurisdictions. The A1 publication indicates the patent application has completed substantive examination and is proceeding to national phase.

This is a patent grant notice that does not create compliance obligations for third parties. Medical device manufacturers and orthopedic companies should note this intellectual property filing for competitive landscape awareness, freedom-to-operate analysis, and potential licensing considerations. No immediate action is required unless companies are actively developing similar shoulder or joint implant technologies in European markets.